期刊文献+
共找到1篇文章
< 1 >
每页显示 20 50 100
Exosome-mediated aptamer S58 reduces fibrosis in a rat glaucoma filtration surgery model 被引量:3
1
作者 Qian-Yi Lin Xiang-Ji Li +7 位作者 Yu Leng Xiao-Min Zhu Min Tang Yi Lin Wang-Du Luo bing-cai jiang Xia Chen Lin Xie 《International Journal of Ophthalmology(English edition)》 SCIE CAS 2022年第5期690-700,共11页
AIM:To confirm whether exosome-mediated delivery of aptamer S58(Exo-S58) has a better antifibrotic effect than naked S58 in human conjunctival fibroblasts(HCon Fs) and a rat glaucoma filtration surgery(GFS) model.METH... AIM:To confirm whether exosome-mediated delivery of aptamer S58(Exo-S58) has a better antifibrotic effect than naked S58 in human conjunctival fibroblasts(HCon Fs) and a rat glaucoma filtration surgery(GFS) model.METHODS:To enhance the effective reaction time of aptamer S58 in vivo, we loaded aptamer S58 into exosomes derived from HEK293 T cells by PEI transfection to determine the effect of Exo-S58 in HCon Fs and a rat GFS model.RESULTS:Exo-S58 can significantly reduce cell proliferation, migration and fibrosis in TGF-β2-induced HCon Fs. In an in vivo experiment, Exo-S58 treatment prolonged filtering bleb retention and reduced fibrosis compared with naked S58 treatment in GFS rats.CONCLUSION:The exosomes are safe and valid carriers to deliver aptamers. Furthermore, Exo-S58 exhibited superior antifibrotic effect than naked S58 both in HCon Fs cells and rat GFS models. 展开更多
关键词 NANOMEDICINE EXOSOMES APTAMER drug delivery glaucoma surgery transforming growth factor-beta ANTI-FIBROSIS
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部